Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 3:14 pm Purchase | 2022-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | LYTTON LAURENCE W | 16,081 4.990% | 2,155 (+15.47%) | Filing History |
| 2023-02-13 2:55 pm Sale | 2022-12-31 | 13G | Crescent Biopharma, Inc. CBIO | LYTTON LAURENCE W | 1,778 7.100% | -2,948 (-62.37%) | Filing History |
| 2023-02-10 7:02 pm Purchase | 2022-12-31 | 13G | EMCORE Corporation EMKR | LYTTON LAURENCE W | 292,327 7.800% | 87,937 (+43.02%) | Filing History |
| 2023-01-19 6:34 pm Purchase | 2023-01-10 | 13G | BIOLASE, Inc. BIOL | LYTTON LAURENCE W | 24,611 9.990% | 24,611 (New Position) | Filing History |
| 2022-11-23 2:40 pm Purchase | 2022-11-14 | 13G | Exagen Inc. XGN | LYTTON LAURENCE W | 833,305 5.100% | 833,305 (New Position) | Filing History |
| 2022-11-23 1:01 pm Purchase | 2022-11-18 | 13G | TFF Pharmaceuticals, Inc. TFFP | LYTTON LAURENCE W | 125,506 8.800% | 125,506 (New Position) | Filing History |
| 2022-05-20 6:45 pm Purchase | 2022-05-11 | 13G | EMCORE Corporation EMKR | LYTTON LAURENCE W | 204,390 5.400% | 139,112 (+213.10%) | Filing History |
| 2022-05-18 4:47 pm Purchase | 2022-05-09 | 13G | Paratek Pharmaceuticals, Inc. PRTK | LYTTON LAURENCE W | 3,210,552 5.900% | 3,210,552 (New Position) | Filing History |
| 2022-03-30 12:48 pm Purchase | 2022-03-02 | 13G | Scientific Industries, Inc. SCND | LYTTON LAURENCE W | 408,229 5.700% | 408,229 (New Position) | Filing History |
| 2022-03-04 5:23 pm Purchase | 2022-02-22 | 13G | Crescent Biopharma, Inc. CBIO | LYTTON LAURENCE W | 4,726 5.900% | 4,430 (+1493.26%) | Filing History |
| 2022-02-15 4:57 pm Purchase | 2021-12-31 | 13G | Apollo Endosurgery, Inc. APEN | LYTTON LAURENCE W | 3,689,920 9.300% | 1,041,770 (+39.34%) | Filing History |
| 2022-02-15 2:25 pm Sale | 2021-12-31 | 13G | DiaMedica Therapeutics Inc. DMAC | LYTTON LAURENCE W | 1,071,970 4.100% | -308,296 (-22.34%) | Filing History |
| 2022-02-15 2:18 pm Sale | 2021-12-31 | 13G | VERTEX ENERGY INC VTNRQ | LYTTON LAURENCE W | 3,649,067 5.700% | -444,494 (-10.86%) | Filing History |
| 2022-02-15 2:16 pm Purchase | 2021-12-31 | 13G | HTG Molecular Diagnostics, Inc. HTGM | LYTTON LAURENCE W | 43,474 6.800% | 3,107 (+7.70%) | Filing History |
| 2022-02-15 1:50 pm Sale | 2021-12-31 | 13G | Ra Medical Systems, Inc. RMED | LYTTON LAURENCE W | 4,400 0.800% | -419 (-8.70%) | Filing History |
| 2022-02-15 1:49 pm Sale | 2021-12-31 | 13G | EMCORE Corporation EMKR | LYTTON LAURENCE W | 65,279 1.800% | -106,552 (-62.01%) | Filing History |
| 2022-02-15 1:48 pm Purchase | 2021-12-31 | 13G | Viracta Therapeutics, Inc. VIRX | LYTTON LAURENCE W | 255,876 0.700% | 255,876 (New Position) | Filing History |
| 2022-02-15 1:09 pm Sale | 2021-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | LYTTON LAURENCE W | 85,416 2.500% | -81,604 (-48.86%) | Filing History |
| 2022-02-14 7:50 pm Sale | 2021-12-31 | 13G | Duos Technologies Group, Inc. DUOT | LYTTON LAURENCE W | 214,700 5.900% | -1,000 (-0.46%) | Filing History |
| 2022-02-14 7:45 pm Purchase | 2021-12-31 | 13G | Giga-tronics Incorporated GIGA | LYTTON LAURENCE W | 274,951 9.990% | 27,251 (+11.00%) | Filing History |